FDA to Vote on Booster Shots From Johnson & Johnson and Moderna
A Food and Drug Administration panel will vote today on whether to recommend Johnson & Johnson and Moderna coronavirus booster shots.
At the same time, the Biden administration is making a push for the vaccine to get approved for emergency use for kids ages five to 11.
Moderna is urging the government to authorize a half-size covid-19 booster dose for some adults.
They say studies show the booster is effective.
But initial results show people who got the Johnson & Johnson vaccine may benefit from a Pfizer or Moderna booster shot more.
The White House says seven million people have already received a Pfizer booster, which was approved for certain Americans last month.
Something they say is positive sign.
The White House coronavirus task force says pediatricians will be the key to vaccinating children.